A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The weight-loss injections, which can cost hundreds of pounds a month, are desi… ...

Mounjaro is unique because it's the first medication approved that targets both these hormones, offering better blood sugar control and weight loss compared to existing GLP-1 receptor agonists.

Comedian Jim Gaffigan credited Mounjaro for his 50-pound weight loss, as he highlighted health benefits. Celebrities Rosie O'Donnell and Amy Schumer also praised the drug.

Weight-loss jab Mounjaro – dubbed the “King Kong” of similar medicines – helps people shed significantly more weight than rival Wegovy, new research suggests. Key research pitching the ...

Eli Lilly launched the weight-loss drug Mounjaro in India two months ago. Mounjaro competes with Novo Nordisk's upcoming Ozempic in India. Demand for Mounjaro is high, especially in Tier 1 cities ...

A PRESENTER has candidly opened up on her “absolutely horrendous” experience while using Mounjaro. Danielle Mason, an ex-Loaded model and TV star, who lied to doctors to get fat jabs ...

Meghan Trainor, at the Billboard Women in Music 2025 on March 29, thanked Mounjaro for her dramatic weight loss. (Christopher Polk/Billboard via Getty Images) "No, I don’t look like I did 10 ...

Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding weight loss alongside diabetes treatment. Thursday, Jun 19, 2025.

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight management and diabetes treatment. Offering a dual-action mechanism targeting ...

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with we. Sign In. TOI. Go to TOI. Etimes. home.

The dual action mechanism sets Mounjaro apart from older GLP-1 receptors like Ozempic (semaglutide)—potentially making it more effective for both blood sugar control and weight loss.

Participants in the SURPASS programme achieved average A1C reductions between 1.8% and 2.1% for Mounjaro 5 mg and between 1.7% and 2.4% for both Mounjaro 10 mg and Mounjaro 15 mg over the period ...